China Life Insurance Company Limited (SHA:601628)
37.30
-0.09 (-0.24%)
Apr 2, 2025, 1:45 PM CST
SHA:601628 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Premiums & Annuity Revenue | 203,090 | 207,719 | 178,459 | 569,671 | 571,391 | Upgrade
|
Total Interest & Dividend Income | -30,022 | 42,994 | 54,205 | 231,470 | 103,569 | Upgrade
|
Gain (Loss) on Sale of Investments | 118,449 | -50,267 | -8,751 | -26,420 | 86,469 | Upgrade
|
Other Revenue | 22,924 | 18,929 | 12,693 | 19,973 | 17,434 | Upgrade
|
Total Revenue | 314,441 | 219,375 | 236,606 | 794,694 | 778,863 | Upgrade
|
Revenue Growth (YoY) | 43.34% | -7.28% | -70.23% | 2.03% | 13.01% | Upgrade
|
Policy Benefits | 175,095 | 145,915 | 125,340 | 603,685 | 575,805 | Upgrade
|
Policy Acquisition & Underwriting Costs | 1,798 | 1,731 | 1,499 | 65,744 | 84,361 | Upgrade
|
Selling, General & Administrative | 7,378 | 6,307 | 6,375 | 42,120 | 38,935 | Upgrade
|
Other Operating Expenses | 8,740 | 14,199 | 11,653 | 31,744 | 12,331 | Upgrade
|
Total Operating Expenses | 193,011 | 166,645 | 144,867 | 744,669 | 711,157 | Upgrade
|
Operating Income | 121,430 | 52,730 | 91,739 | 50,025 | 67,706 | Upgrade
|
Interest Expense | -4,200 | - | - | - | -13,027 | Upgrade
|
Currency Exchange Gain (Loss) | -25 | -381 | -69 | 645 | 119 | Upgrade
|
Other Non Operating Income (Expenses) | -82 | - | -336 | 87 | 79 | Upgrade
|
EBT Excluding Unusual Items | 117,123 | 52,349 | 91,334 | 50,757 | 54,877 | Upgrade
|
Gain (Loss) on Sale of Assets | 88 | 73 | 122 | 69 | 36 | Upgrade
|
Asset Writedown | -1,611 | -71 | -21,396 | -88 | -83 | Upgrade
|
Other Unusual Items | -387 | -363 | - | -398 | -354 | Upgrade
|
Pretax Income | 115,213 | 51,988 | 70,060 | 50,340 | 54,476 | Upgrade
|
Income Tax Expense | 6,273 | -719 | 1,948 | -1,917 | 3,103 | Upgrade
|
Earnings From Continuing Ops. | 108,940 | 52,707 | 68,112 | 52,257 | 51,373 | Upgrade
|
Minority Interest in Earnings | -2,005 | -1,523 | -1,432 | -1,491 | -1,116 | Upgrade
|
Net Income | 106,935 | 51,184 | 66,680 | 50,766 | 50,257 | Upgrade
|
Preferred Dividends & Other Adjustments | - | - | - | - | 201 | Upgrade
|
Net Income to Common | 106,935 | 51,184 | 66,680 | 50,766 | 50,056 | Upgrade
|
Net Income Growth | 108.92% | -23.24% | 31.35% | 1.01% | -13.78% | Upgrade
|
Shares Outstanding (Basic) | 28,265 | 28,265 | 28,254 | 28,265 | 28,265 | Upgrade
|
Shares Outstanding (Diluted) | 28,265 | 28,265 | 28,254 | 28,265 | 28,265 | Upgrade
|
Shares Change (YoY) | - | 0.04% | -0.04% | - | - | Upgrade
|
EPS (Basic) | 3.78 | 1.81 | 2.36 | 1.80 | 1.77 | Upgrade
|
EPS (Diluted) | 3.78 | 1.81 | 2.36 | 1.80 | 1.77 | Upgrade
|
EPS Growth | 108.84% | -23.30% | 31.40% | 1.47% | -13.58% | Upgrade
|
Free Cash Flow | 374,816 | 380,195 | 342,208 | 280,863 | 296,550 | Upgrade
|
Free Cash Flow Per Share | 13.26 | 13.45 | 12.11 | 9.94 | 10.49 | Upgrade
|
Dividend Per Share | 0.650 | 0.430 | 0.490 | 0.650 | 0.640 | Upgrade
|
Dividend Growth | 51.16% | -12.25% | -24.62% | 1.56% | -12.33% | Upgrade
|
Operating Margin | 38.62% | 24.04% | 38.77% | 6.30% | 8.69% | Upgrade
|
Profit Margin | 34.01% | 23.33% | 28.18% | 6.39% | 6.43% | Upgrade
|
Free Cash Flow Margin | 119.20% | 173.31% | 144.63% | 35.34% | 38.07% | Upgrade
|
EBITDA | 125,559 | 57,746 | 95,528 | 53,553 | 70,937 | Upgrade
|
EBITDA Margin | 39.93% | 26.32% | 40.37% | 6.74% | 9.11% | Upgrade
|
D&A For EBITDA | 4,129 | 5,016 | 3,789 | 3,528 | 3,231 | Upgrade
|
EBIT | 121,430 | 52,730 | 91,739 | 50,025 | 67,706 | Upgrade
|
EBIT Margin | 38.62% | 24.04% | 38.77% | 6.30% | 8.69% | Upgrade
|
Effective Tax Rate | 5.45% | - | 2.78% | - | 5.70% | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.